Neurologists' Comfort with tPA Treatment Increasing
US neurology residents have become increasingly comfortable with the use of tissue plasminogen activator (tPA) in patients with stroke, shows an analysis of data from the past decade.
A previous survey of neurology residents who were in their final year in 2000 found that 73% of 287 respondents felt comfortable using tPA in stroke patients.
The follow-up survey, of 491 final-year neurology residents in 2010, reveals that 94% of 286 respondents feel comfortable with providing tPA treatment.
"This is good news," said lead researcher Brett Cucchiara (University of Pennsylvania, Philadelphia, USA). "It is imperative that neurology residents attain a level of comfort using tPA that will allow them to use the medication effectively in their clinical practice and guide other physicians in its use."
National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.